US HB7472 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on April 7 2022 - 25% progression, died in committee
Action: 2022-04-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 7 2022 - 25% progression, died in committee
Action: 2022-04-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to grant eligible researchers access to eligible products at a discounted price for qualified research, and for other purposes.
Title
Discounted Drugs for Clinical Trials Act
Sponsors
Rep. Carolyn Maloney [D-NY] | Sen. Peter Welch [D-VT] | Rep. Janice Schakowsky [D-IL] | Rep. Katie Porter [D-CA] |
Rep. Mark DeSaulnier [D-CA] | Rep. Jamie Raskin [D-MD] |
History
Date | Chamber | Action |
---|---|---|
2022-04-08 | House | Referred to the Subcommittee on Health. |
2022-04-07 | House | Referred to the House Committee on Energy and Commerce. |
2022-04-07 | House | Introduced in House |
Same As/Similar To
SB4026 (Related) 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4053 (Related) 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4053 (Related) 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/7472/all-info |
Text | https://www.congress.gov/117/bills/hr7472/BILLS-117hr7472ih.pdf |